Sleep Disorders Treatment Market Share

Statistics for the 2023 & 2024 Sleep Disorders Treatment market share, created by Mordor Intelligence™ Industry Reports. Sleep Disorders Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Sleep Disorders Treatment Industry

The sleep disorders market is moderately fragmented, with several manufacturers offering generics. Although few players offer branded drugs, price sensitivity is an issue in several regions. Companies focus on developing new chemical entities and novel molecules to obtain a higher revenue share. The major players include companies such as Takeda Pharmaceuticals USA Inc., Vanda Pharmaceuticals Inc., Merck & Co., Mylan NV, Pfizer, and Teva Pharmaceuticals USA Inc.

Sleep Disorder Treatment Market Leaders

  1. Merck & Co

  2. Mylan N.V.

  3. Pfizer

  4. Takeda Pharmaceutical Company Limited

  5. Teva Pharmaceutical Industries Ltd.

*Disclaimer: Major Players sorted in no particular order

Sleep Disorders Treatment Market Concentration

Sleep Disorder Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)